Sernova Corp. is a clinical stage regenerative medicine company, which engages in the development and commercialization of proprietary technologies, including Cell Pouch implantable device technologies and immune-protected therapeutic cells. The company was founded on August 19, 1998 and is headquartered in London, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company